Rabeprazole & Ondansetron Tablets – RABAVAL O Tablets

RABAVAL O Tablets
Composition:- Rabeprazole 20 mg + Ondansetron 4 mg

RABAVAL O Tablets – The Dual combination of Rabeprazole & Ondansetron Tablets is designed to treat acid reflux, gastritis, and nausea-related symptoms effectively.
Rabeprazole is a proton pump inhibitor (PPI) that inhibits gastric acid secretion, reducing heartburn, GERD, and ulcers. Ondansetron is a 5-HT3 receptor antagonist that blocks nausea and vomiting signals, making it ideal for acid reflux with nausea, chemotherapy-induced nausea, or post-surgical nausea.
This combination improves digestive comfort, prevents regurgitation, and ensures overall gastric well-being.
Marketed by: Wonne International Pvt. Ltd.

Key Points of Rabeprazole and Ondansetron Tablets – RABAVAL O Tablets
• Dual Action for Acid Control & Nausea Relief – Rabeprazole effectively suppresses acid production, while Ondansetron prevents nausea and vomiting, providing comprehensive relief.
• Superior to PPIs Alone – Addresses both gastric acid disorders and nausea-related symptoms, making it ideal for acid reflux with associated nausea or vomiting.
• Fast-Acting and Long-Lasting – Ondansetron provides quick nausea relief, while Rabeprazole ensures prolonged acid suppression, reducing the need for multiple medications.

• Gastroenterologists
• General Physicians
• Oncologists
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.